ADTX Stock Analysis: Buy, Sell, or Hold?
ADTX - Aditxt, Inc. Common Stock
$0.74
-0.06 (-7.00%)
▼
5d:
-23.39%
30d:
-16.18%
90d:
+1156.78%
WAIT
LOW Confidence
Last Updated: February 3, 2026
Earnings: Feb 16, 2026
12d
Get Alerted When ADTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ADTX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ADTX is down 23.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ADTX is down 23.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ADTX is currently trading at $0.74, which is considered oversold relative to its 30-day fair value range of $0.75 to $1.09.
Technical Outlook: Technically, ADTX is showing sideways momentum. Immediate support is located at $0.71, while resistance sits at $1.84. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $61.00 (+7550.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ADTX is showing sideways momentum. Immediate support is located at $0.71, while resistance sits at $1.84. Short-term momentum is weak, with the stock down 7.0% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $61.00 (+7550.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.75 -
$1.09
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.0%)
- BULLISH: Trading 7550.8% below Wall St target ($61.00)
- WARNING: Recommendation downgraded due to -23.4% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.75 -
$1.09
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.71
Resistance Level
$1.84
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
0.37
Wall Street Target
$61.00
(+7550.8%)
Revenue Growth (YoY)
-89.1%
Last updated: February 03, 2026 1:13 PM ET
Data refreshes hourly during market hours. Next update: 2:13 PM
Data refreshes hourly during market hours. Next update: 2:13 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 61 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 63 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 54 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 56 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 59 HOLD |
